Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients

Clinical Cancer Research

Volumn 2, Issue 5, 1996, Pages 821-826

  Yamamoto, Yutaka ^a   Toi, Masakazu ^a   Kondo, Shinichi ^b   Matsumoto, Tomoe ^b   Suzuki, Hideo ^b   Kitamura, Masatsugu ^a   Tsuruta, Koji ^a   Taniguchi, Tadaaki ^a   Okamoto, Atsutake ^a   Mori, Takeo ^a   Yoshida, Misao ^a   Ikeda, Takaaki ^a   Tominaga, Takeshi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Base Technology Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BLOTTING, WESTERN; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 9344236065     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
2. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
3. Weidner, N., Sample, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Moscatelli, D., and Rifkin, D. B. Membrane and matrix localization of proteases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys. Acta, 948: 67-85, 1988.
5. Goldfarb, M. The fibroblast growth factor family. Cell Growth & Differ., 1: 439-445, 1990.
6. Tisher, E., Gospodarowicz, D., Mitchell, R., Silva, M., Shilling, J., Lau, K., Crisp, T., Fiddes, J. C., and Abraham, J. A. Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem. Biophys. Res. Commun., 165: 1198-1206, 1989.
7. Schrieber, A. B., Winkler, M. E., and Derynck, R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science (Washington DC), 232: 1250-1253, 1986.
8. Ishikawa, F., Miyazono, K., Hellman, U , Drexler, H., Werustedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
9. Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnoue, L., Coffer, A., and Comoglio, P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119: 629-641, 1992.
10. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
11. Kondo, S., Asano, M., and Suzuki, H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem. Biophys. Res. Commun. 194: 1234-1241, 1993.
12. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
13. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161: 851-858, 1989.
14. Leung, D. W., Cachianes, G., Kuang, W., Goeddel, D. V., and Ferrara, N Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
15. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Reder, J., and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.
16. Houch, K. A., Ferrara, N., Winer, H., Cachianes, G., Li, B., and Leung, D. W. The vascular endothelial growth factor family. Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5: 1806-1814, 1991.
17. Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85: 1045-1049, 1994.
18. Plate, K. H., Breire, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
19. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinoma of gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
20. Brown, S. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma. Am. J. Pathol., 143: 1255-1262, 1993.
21. Olson, T. A., Mohanraj, D., Carson, L. F., and Ramakrishnan, S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res., 54: 276-280, 1994.
22. Zhang, H. T., Craft, P., Scott, P., Ziech, M., Weich, H. A., Harris, A. L., and Bicknell, R. Expression of vascular endothelial growth factor in MCF-7 cells enhances tumor growth and vascular density J. Natl. Cancer Inst., 87: 213-219, 1995.
23. Kondo, S., Matsumoto, T., Yokoyama, Y., Ohmori, I., and Suzuki, H. The shortest isoform of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochim. Biophys. Acta, 1243: 195-202, 1995.
24. Asano, M., Yukita, A., Matsumoto, T., Matsuo, K., Kondo, S., and Suzuki, H. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor 121 (VEGF/VPF121). Hybridoma. 14: 475-480, 1995.
25. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
26. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell, 79: 315-328, 1994.
27. Yeo, K-T., Wang, H. H., Nagy, J. A., Sioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, E. M., Senger, D. R., Dvorak, H. F., and Yeo, T-K. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res., 53: 2912-2918, 1993.
28. Kondo, S., Asano, M., Matsuo, K., Ohmori, I., and Suzuki, H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta, 1221: 211-214, 1994.
29. Hanatani, M., Tanaka, Y., Kondo, S., Ohmori, I., and Suzuki, H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci. Biotechnol. Biochem., 59: 1958-1959, 1995.
30. Ferrara, N., Houch, K. A., Jakeman, L. B., Winer, J., and Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47: 211-218, 1991.
31. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. Definition of two angiogenic pathways by distinct α, integrins. Science (Washington DC), 270: 1500-1502, 1995.
32. Park, J. E., Keller, G. A., and Ferrara, N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell, 4: 1317-1326, 1993.
33. Boocock, C. A., Charnock-Jones, S., Sharkey, A. M., McLaren, J., Barker, P. J., Wright, K. A., Twentyman, P. R., and Smith, S. K. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl. Cancer Inst., 87: 506-516, 1995.
34. Kurobe, M., Kato, A., Takei, Y , and Hayashi, K. Fluorometric enzyme immunoassay of basic fibroblast growth factor with monoclonal antibodies. Clin. Chem., 38, 2121-2123, 1992.
35. Ii, M., Yoshida, H., Aramaki, Y., Masuya, H., Hada, T., Terada, T., Hatanaka, M , and Ichimori, Y. Improved enzyme immunoassay for human basic fibroblast growth factor using a new enhanced chemiluminescence system Biochem. Biophys. Res. Commun., 193: 540-545, 1993.
36. Takei, Y., Kurobe, M., Uchida, A., Hayashi, K. Serum concentrations of basic fibroblast growth factor in breast cancer. Clin. Chem., 40: 1980-1981, 1994.
37. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. 86: 356-361, 1994.
38. Chakrabarty, S., Huang, S., Moskal, T L., and Fritsche, H. A., Jr. Elevated serum levels of transforming growth factor-α in breast cancer patients. Cancer Lett., 79: 157-160, 1990.
39. Taniguchi, T., Toi, M., Inada, K., Imazawa, T., Yamamoto, Y., and Tominaga, T. Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin. Cancer Res., 1: 1031-1034, 1995.
40. Gasparini, G., and Harris, A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13: 765-782, 1995.